Genomics Assessment Platform

How this assessment platform benefits ONDRI’s research

ONDRI’s research investigates how a person’s genetic makeup and genetic patterns may explain why some people are more likely to get neurodegenerative diseases than others.

Video: The genomics assessment

To access closed captioning, or read the words, click on CC at bottom of the video

ONDRI protocol

Participants visit a medical laboratory where a blood sample is taken.

DNA is isolated from the blood samples by ONDRI expert researchers. This DNA is then analyzed to identify changes that may contribute to neurodegenerative disease development or presentation.

This assessment was used in the following studies:

For details on data collected through the genomics assessment platformclick here.

Related resources:

ONDRISeq: a custom gene panel for neurodegeneration
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Genetic variation in the ONDRI study cohort
PD, NOTCH3 Genetic Variants, & White Matter Hyperintensities

Learn about ONDRI’s other assessment platforms

Clinical
Neuroimaging
Eye Tracking
Neuroinformatics & Biostatistics
Gait (Walking) & Balance
Neuropsychology
Genomics
Remote Patient Monitoring
Molecular/ Neuropathology
Retinal Thickness